RMEI provides up-to-date continuing education in a wide variety of therapeutic areas, and presented by expert faculty. Choose from the menu to view our cutting-edge programs on CME topics in your content area.

A Multidisciplinary Approach to Managing HCC

The management of unresectable hepatocellular carcinoma (HCC) involves recognizing and managing adverse events and effectively working with a multidisciplinary team. This Clinical ForumSM brings together an interventional radiologist, oncologist, and hepatologist to discuss how they work together at their institutions to achieve a common goal.

 

An Immersive Virtual Patient Simulation

Interact with virtual patients and physicians to learn practical, data-driven strategies that will help you diagnose and treat multiple sclerosis(MS).

 

Clinical Convergence®: Approaching Chronic Urticaria from the Patient Perspective

This activity is designed to engage your critical thinking and challenge suboptimal approaches to patient care. It features videos of 2 patients with chronic urticaria (CU) and challenging interactive questions related to their histories and treatments. You will have an opportunity to hear the patients’ perspectives of CU, and learn from our expert faculty.

Clinical Convergence®: Child and Adolescent Bipolar Depression

In this educational activity, which is based on a symposium held during the American Psychiatric Nurses Association 17th Annual Clinical Psychopharmacology Institute meeting, you will hear from a live adolescent patient with bipolar disorder and her caregiver, as well as 2 faculty experts. You will have an opportunity to learn more about the diagnosis and treatment for pediatric and adolescent bipolar disorder through challenging clinical case presentations, clinical questions, and a panel discussion highlighting the personal impact of bipolar disorder.

 

Clinical Exchanges®: Detangling Difficult Conversations About Multiple Sclerosis

This conversation-centered activity with educational pearls takes learners through a clinical exchange between patients with multiple sclerosis and their providers.

Clinical Exchanges®: Optimizing Management of Nontuberculous Mycobacteria Lung Disease

The successful management of nontuberculous mycobacteria lung disease (NTM-LD) remains challenging owing to the need for long-term treatment, the ongoing risks of adverse drug reactions, and the potential for nonadherence. These factors underscore the importance of specialty referral and shared decision making in the successful management of NTM-LD, as Dr. Anne O’Donnell and her patient Brinkley exemplify.

 

Clinical Reflections®: Multiple Sclerosis Diagnosis and Management Strategies

Discover scenarios of patients with multiple sclerosis followed by assessment and management questions that explore how the patients can be managed optimally.

 

Clinical Reflections®: Reflecting on Errors and Missed Opportunities in Chronic Urticaria

This unique educational initiative harnesses the power of reflection and recognition of suboptimal approaches to patient care to allow you to rethink clinical decisions based on the scenarios presented, and to modify treatment plans accordingly. You can compare your responses to interactive questions with those of your peers and learn from our expert faculty.

Clinical Reflections®: Reflecting on Missed Opportunities in Nontuberculous Mycobacteria Lung Disease

Nontuberculous mycobacteria lung disease (NTM-LD) is a relatively uncommon condition, although its prevalence is rising. In this interactive CME activity, Drs. Anne O’Donnell and Patrick Flume review 2 patient cases to demonstrate how clinicians can maintain a greater index of suspicion for the diagnosis of NTM-LD to enable timely and effective therapy. The management of NTM-LD remains challenging, owing to the need for long-term treatment, the potential for drug-related toxicities, and patient nonadherence. These factors underscore the importance of specialty referral for the successful management of NTM-LD.

 

Combating Residual Risk with Treatment Intensification: Focus on PCSK9 Inhibitors - A Care Team Forum℠

The panel will delve into topics covering safety/efficacy data for PCSK9 inhibitors (PCSK9-Is), 2018 ACC/AHA guideline updates, and patient selection for treatment intensification with PCSK9-Is. Faculty will examine key matters in patient care, provide illustrative patient case scenarios, pose practical solutions to common issues encountered in clinical practice, and Charles will provide insight into his experience with familial hypercholesterolemia, its treatment, and his interaction with the healthcare system.

 

 

Current Landscape in IBD and Unmet Needs

Advances in inflammatory bowel disease (IBD) treatment have improved outcomes for many patients but personalizing therapy and predicting response to therapy is a huge challenge. This has led to underutilization of effective regimens, undertreatment, and suboptimal outcomes. This activity reviews how new and emerging clinical decision support tools can help providers bridge this gap by predicting individualized disease complication risk and response to therapy.

 

CUTANEOUS SQUAMOUS CELL CARCINOMA CE COURSES

Diagnosing and Managing Multiple Sclerosis: A Personalized Approach

With rapidly changing guidelines and treatment indications, it can be difficult discerning when to start a disease-modifying therapy in the early spectrum of multiple sclerosis (MS), such as clinically and radiologically isolated syndrome; how to discuss MS management in women of childbearing age; or how to use the new guidelines to confirm an MS diagnosis. In this supplement, these topics will be addressed along with recognizing treatment failure, knowing when to switch therapies, and how to incorporate patient preference in treatment-related decisions.

Early Diagnosis and Augmentation for Alpha-1 Antitrypsin Deficiency Lung Disease: A Care Team Forum℠

This activity is designed to engage your critical thinking about patients who may have alpha-1 antitrypsin deficiency (AATD) and to challenge suboptimal approaches to the management of patients with AATD lung disease. You will hear unique insights from 3 clinical experts and a patient living with AATD during this dynamic presentation.

Experts-in-the-Hot Seat: Emerging Trends in Managing Hemophilia A

In this CME activity, you will hear insights from 3 hemophilia experts on the current management approach to hemophilia A with and without inhibitors, new developments in hemophilia A therapies, and ways to incorporate shared decision making when treating patients with hemophilia A. In addition, you will have an opportunity to practice through a series of questions and compare yourself to your peers.

 

IBD in Clinical Practice: Diagnosis and Medical Treatment 2019

Join leading inflammatory bowel disease (IBD) experts in this interactive activity where you will have the opportunity to follow a patient to learn about the diagnosis and management of IBD. Be sure to check out the Crohn's & Colitis Foundation resources as well as a comprehensive reading list related to the learning objectives following the closing commentary section of the activity.

 

IBD in Clinical Practice: Long-term Disease Management and Surgery - 2019

Join leading inflammatory bowel disease (IBD) experts in this interactive activity where you will have the opportunity to follow a patient to learn about the long-term management and surgery indications of IBD. Be sure to check out the Crohn's & Colitis Foundation resources as well as a comprehensive reading list related to the learning objectives following the closing commentary section of the activity.

 

Immunotherapy: Changing Patient Outcomes in SCLC

This activity offers expert insight into the practice-changing evidence on immunotherapy for the management of extensive-stage small cell lung cancer.

Integration of Immunotherapy into Treatment for Hematological Malignancies

This enduring activity will provide learners with the latest developments in immunotherapy for leukemia, lymphoma, and myeloma and how these developments can be incorporated into regimens to improve the outcome of patients with these diseases.

Managing Sleep Maintenance Insomnia in Older Adults

This activity provides evidence-based insights, with an emphasis on current gaps in sleep maintenance insomnia. You will learn about the current challenges associated with managing sleep maintenance insomnia and how to utilize currently available and emerging treatments for management, especially in your older and elderly patients.

 

New Systemic Therapies in Hepatocellular Carcinoma

For over a decade, sorafenib was the only systemic agent available for the treatment of advanced hepatocellular carcinoma. However, the past 2.5 years has added 6 additional agents. In this Clinical ForumSM, our multidisciplinary expert roundtable convenes to discuss their collaborative care strategies for first and subsequent line management of advanced hepatocellular carcinoma (HCC) using case-based scenarios.

 

Obtaining Authorization for PCSK9 Inhibitors: A Care Team Forum

In this interactive roundtable discussion, Charles, his doctor, and 2 other prominent clinical experts gather to deliberate over reimbursement issues surrounding the clinical use of PCSK9-Is and offer practical strategies to facilitate navigating the prior authorization and appeals process.

 

Safely and Effectively Managing Sleep Maintenance Insomnia in Older Adults

In this activity, you will learn about the impact and management of sleep maintenance insomnia, including current approaches as well as novel and emerging treatments.

 

Sniffing Out the Problem: A Dive into Management for Chronic Rhinosinusitis with Nasal Polyps

Chronic rhinosinusitis with nasal polyps (CRSwNP) is associated with significant morbidity and negatively impacts quality of life. The good news is that biologic therapies targeting type 2 inflammatory pathways provide additional treatment options for CRSwNP. However, clinicians not only need to accurately diagnose nasal polyps in patients but also recognize the role of the underlying pathology to incorporate biologic agents into treatment regimens when appropriate, as Dr. Joseph K. Han explains.

Tackling Influenza in High-Risk Populations: Early Diagnosis and Treatment is Crucial to Improve Outcomes

Most people recover from uncomplicated influenza, but influenza can cause complications that result in severe illness and death. Some patients are at higher risk of experiencing these complications. In this program, physicians specializing in family medicine, internal medicine, and emergency medicine discuss their clinical experience about managing patients who develop symptoms of influenza and are at high risk of complications. They also explain recent changes to national guidelines. A patient who developed symptoms of influenza and was at high risk of complications shares his experience with testing and treatment for influenza.